Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

RCE at ESMO 2014

RCE at ESMO 2014
Start date
26 Sep 2014
End date
30 Sep 2014
Madrid, Spain

What Rare Cancer Europe is up to at ESMO 2014

RCE Press Conference: The methodology of clinical trials in rare tumors

Saturday 27 September from 12:15-13:00 Press Conference room
Moderator: Jean-Yves Blay

Rare Cancers Europe methodological recommendations for clinical studies in rare cancers, a multi-stakeholder position paper calling for different criteria to be used in clinical trials for rare cancers treatments. How to address:

  1. Challenges of taking clinical decisions in rare cancers, Paolo Casali, ESMO
  2. Challenges in designing clinical trials in rare cancers, Vassilis Golfinopoulos, EORTC
  3. Challenges in rare cancer patients referral, Markus Wartenberg, SPAEN

Access the RCE Press Release: Specific clinical trial methodology needed for rare cancers

Special Session: How clinical trials could have been done, and were not, in rare cancers

Monday 29. 16:00-17:30 - Room BILBAO
Chairs: Jan Bogaerts, Paolo Casali

16:00-16:15 Introduction
16:15-16:30 CNS Clinicians
16:30-16:45 CNS Statisticians
16:45-17:00 Sarcoma clinicians
17:00-17:15 sarcoma Statisticians
17:15-17:30 Methodological challenges in rare cancers

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.